According to the NCI website, Selumetinib is an orally bioavailable small molecule with potential antineoplastic activity.

Link to Drug Information Portal, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to MedlinePlus, a service of the U.S. National Library of Medicine, National Institutes of Health
Link to National Cancer Institute
Link zu Wiki

MaP-Kinase-Weg